Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sandoz Canada is a leading pharmaceutical company specializing in generic medicines and biosimilars, serving as a key player in the Canadian healthcare landscape. As a subsidiary of the globally independent Sandoz Group AG, the company provides a broad portfolio of over 700 products covering various therapeutic areas such as oncology, infectious diseases, and endocrinology. Sandoz Canada is particularly recognized for its leadership in the biosimilars market, offering high-quality alternatives to complex biologic drugs to improve patient access and healthcare sustainability. The company operates a major production and distribution facility in Boucherville, Quebec, which serves as a hub for its Canadian operations. Through its commitment to innovation in off-patent medicines, Sandoz Canada helps generate significant cost savings for public and private drug insurance plans across the country.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sandoz Canada.